Immutep Receives Positive EMA Scientific Advice for Further Clinical Development of Efti in MBC Including Phase III

Thursday, October 28, 2021 1 min read

Key Takeaway: Immutep Receives Positive EMA Scientific Advice for Further Clinical Development of Efti in MBC Including Phase III

Full Press Release Details

Immutep Receives Positive EMA Scientific Advice for Further Clinical Development of Efti in MBC Including Phase III.